Pain 2005: Vol 113 Index

2005·4.1 MB·English

PAIN
Pain 113 (2005) 431-434
www.elsevier.com/locate/pain
Author Index to Volume 113 (2005)
Adelson, M., see Peles, E., 113 340 Clark, A.J., see Sullivan, M.J.L., 113 310
Aiken, L.S., see Ruehlman, L.S., 113 82 Clayton, C.C., see Morgan, M.M., 113 91
Ait-Belgnaoui, A., Bradesi, S., Fioramonti, J., Theodorou, V., Bueno, L., Conklin, D., see Obata, H., 113 271
Acute stress-induced hypersensitivity to colonic distension depends Conklin, D.R., see Martin, T.J., 113 376
upon increase in paracellular permeability: role of myosin light chain Convers, P., see Montes, C., 113 223
kinase, 113 141 Cousins, M.J., see Blyth, F.M., 113 285
Albers, K.M., see Molliver, D.C., 113 277 Cowan, P., see Dworkin, R.H., 113 9
Allen, R.R., see Dworkin, R.H., 113 9 Crane, P., see Von Korff, M., 113 331
Anderson, K.O., Role of cutpoints: why grade pain intensity?, 113 5 Crombez, G., see Eccleston, C., 113 7
Anzenhofer, S., see Sycha, T., 113 316 Crombez, G., see Gheldof, E.L.M., 113 71
Arendt-Nielsen, L., see Ge, H.-Y., 113 134
Dahl, J.B., see Duedahl, T.H., 113 360
Bach, F.W., Jensen, T.S., Sindrup, S.H., Rasmussen, P.V., Response letter Dai, Y., see Mizushima, T., 113 51
regarding Thompson, 113 245 Davis, B.M., see Molliver, D.C., 113 277
Bakalkin, G., see Tan-No, K., 113 301 Davis, K.D., see Kwan, C.L., 113 160
Baker, M.D., see Stirling, L.C., 113 27 DeLander, G.E., see Wu, W.-P., 113 395
Balderson, B.H.K., see Von Korff, M., 113 323 Dey, D.D., Landrum, O., Oaklander, A.L., Central neuropathic itch from
Bantel, C., see Ma, W., 113 386 spinal-cord cavernous hemangioma: a human case, a possible animal
Bell, A.C., see Gilron, I., 113 191 model, and hypotheses about pathogenesis, 113 233
Bellamy, N., see Dworkin, R.H., 113 9 Diamant, N.E., see Kwan, C.L., 113 160
Berry, S., see Von Korff, M., 113 323 Dickenson, A.H., see Hansson, P.T., 113 251
Bianchini, K.J., see Greve, K.W., 113 245 Dickenson, A.H., see Stirling, L.C., 113 27
Bjoro, T., see Hagen, K., 113 416 Dionne, R., see Dworkin, R.H., 113 9
Blyth, F.M., March, L.M., Nicholas, M.K., Cousins, M.J., Self-manage- Dirks, J., see Duedahl, T.H., 113 360
ment of chronic pain: a population-based study, 113 285 Duedahl, T.H., Dirks, J., Petersen, K.B., Romsing, J., Larsen, N.-E., Dahl,
Boivin, M., see Strigo, I.A., 113 255 J.B., Intravenous dextromethorphan to human volunteers: relationship
Borszcz, G.S., see Harte, $.E., 113 405 between pharmacokinetics and anti-hyperalgesic effect, 113 360
Bovim, G., see Hagen, K., 113 416 Duncan, G.H., see Strigo, I.A., 113 255
Bowsher, D., Pain, 113 430 Dworkin, R.H., Turk, D.C., Farrar, J.T., Haythornthwaite, J.A., Jensen, M.P.,
Boyer-Quick, J.S., see Morgan, M.M., 113 91 Katz, N.P., Kerns, R.D., Stucki, G., Allen, R.R., Bellamy, N., Carr, D.B.,
Brack, A., see Puehler, W., 113 427 Chandler, J., Cowan, P., Dionne, R., Galer, B.S., Hertz, S., Jadad, A.R.,
Bradesi, S., see Ait-Belgnaoui, A., 113 141 Kramer, L.D., Manning, D.C., Martin, S.,. McCormick, C.G., McDermott,
Brandenburg, N., see Von Korff, M., 113 331 M.P., McGrath, P., Quessy, S., Rappaport, B.A., Robbins, W., Robinson,
Buechler, N., see Martin, T.J., 113 376 J.P., Rothman, M., Royal, M.A., Simon, L., Stauffer, J.W., Stein, W.,
Bueno, L., see Ait-Belgnaoui, A., 113 141 Tollett, J., Wernicke, J., Witter. J., Core outcome measures for chronic
Buffington, A.L.H., Hanlon, C.A., McKeown, M.J., Acute and persistent pain clinical trials: IMMPACT recommendations, 113 9
pain modulation of attention-related anterior cingulate fMRI activa-
tions, 113 172 Eccleston, C., Crombez, G., Attention and pain: merging behavioural and
Burkey, T.H., see Fehrenbacher, J.C., 113 113 neuroscience investigations, 113 7
Bushnell, M.C., see Strigo, 1.A., 113 255 Edwards, R.R., see Campbell, C.M., 113 20
Eichler, H.-G., see Sycha, T., 113 316
Campbell, C.M., Edwards, R.R., Fillingim, R.B., Ethnic differences in Eisenach, J.C., see Ma, W., 113 386
responses to multiple experimental pain stimuli, 113 20 Eisenach, J.C., see Martin, T.J., 113 376
Carr, D.B., see Dworkin, R.H., 113 9 Eisenach, J.C., see Obata, H., 113 271
Chandler, J., see Dworkin, R.H., 113 9 Eisenberg, E., Response to Reuben SS: *‘The prevention of post-surgical
Chibnall, J.T., Tait, R.C., Confirmatory factor analysis of the Pain Cata- neuralgia’, 113 243
strophizing Scale in African American and Caucasian Workers’ Eisenberg, E., Chistyakov, A.V., Yudashkin, M., Kaplan, B., Hafner, H..
Compensation claimants with low back injuries, 113 369 Feinsod, M., Evidence for cortical hyperexcitability of the affected limb
Chistyakov, A.V., see Eisenberg, E., 113 99 representation area in CRPS: a psychophysical and_ transcranial
Chizh, B., see Sycha, T., 113 316 magnetic stimulation study, 113 99
Christidis, N., Kopp, S., Ernberg, M., The effect on mechanical pain thresh- Elia, N., Tramér, M.R., Ketamine and postoperative pain—a quantitative
old over human muscles by oral administration of granisetron and systematic review of randomised trials, 113 61
diclofenac-sodium, 113 265 Elliott, A.M., see Smith, B.H., 113 249
Clark, A.J., see Lynch, M.E., 113 240 Ernberg, M., see Christidis, N., 113 265
doi: 10.1016/S0304-3959(04)00610-4
432 Author Index to Volume 113 (2005) 431-434
Farrar, J.T., see Dworkin, R.H., 113 9 Katz, N.P., see Dworkin, R.H., 113 9
Fehrenbacher, J.C., Burkey, T.H., Nicol, G.D., Vasko, M.R., Tumor necro- Kender, R.G., see Harte, S.E., 113 405
sis factor a and interleukin-1B stimulate the expression of cyclooxy- Kerns, R.D., see Dworkin, R.H., 113 9
genase II but do not alter prostaglandin E, receptor mRNA levels in Kessler, R., see Von Korff, M., 113 331
cultured dorsal root ganglia cells, 113 113 Kopf, A., see Puehler, W., 113 427
Feinsod, M., see Eisenberg, E., 113 99 Kopp, S., see Christidis, N., 113 265
Fillingim, R.B., see Campbell, C.M., 113 20 Kramer, L.D., see Dworkin, R.H., 113 9
Fioramonti, J., see Ait-Belgnaoui, A., 113 141 Kunz, N.R., see Rowbotham, M.C., 113 248
Fitzgerald, C., see Grunau, R.E., 113 293 Kwan, C.L., Diamant, N.E., Mikula, K., Davis, K.D., Characteristics of
Forlani, G., see Stirling, L.C., 113 27 rectal perception are altered in irritable bowel syndrome, 113 160
Fredholm, B.B., see Wu, W.-P., 113 395
Frot, M., see Montes, C., 113 223 LaMotte, R.H., see Ma, C., 113 106
Fukuoka, T., see Mizushima, T., 113 51 Landrum, O., see Dey, D.D., 113 233
Lane, M., see Von Korff, M., 113 331
Galer, B.S., see Dworkin, R.H., 113 9 Lang, B.A., see Reid, G.J., 113 201
Garcia-Larrea, L., see Montes, C., 113 223 Larsen, N.-E., see Duedahl, T.H., 113 360
Ge, H.-Y., Madeleine, P., Arendt-Nielsen, L., Gender differences in pain Lehr, S., see Sycha, T., 113 316
modulation evoked by repeated injections of glutamate into the human Lei, D., see Rowbotham, M.C., 113 248
trapezius muscle, 113 134 Levine, J.D., see Parada, C.A., 113 185
Gheldof, E.L.M., Vinck, J., Vlaeyen, J.W.S., Hidding, A., Crombez, G., Lin, E.H.B., see Von Korff, M., 113 323
The differential role of pain, work characteristics and pain-related fear Lindsay, J., see Molliver, D.C., 113 277
in explaining back pain and sick leave in occupational settings, 113 71 Lévdahl, C., see Wu, W.-P., 113 395
Gilron, I., Orr, E., Tu, D., O’ Neill, J.P., Zamora, J.E., Bell, A.C., A placebo- Luyten, P., see Van Houdenhove, B., 113 238
controlled randomized clinical trial of perioperative administration of Lynch, M.E., see Sullivan, M.J.L., 113 310
gabapentin, rofecoxib and their combination for spontaneous and move- Lynch, M.E., Clark, A.J., Beware somatization et al., 113 240
ment-evoked pain after abdominal hysterectomy, 113 191
Goli, V., see Rowbotham, M.C., 113 248 Ma, C., LaMotte, R.H., Enhanced excitability of dissociated primary
Gordon, J., see Peles, E., 113 340 sensory neurons after chronic compression of the dorsal root ganglion
Greve, K.W., Bianchini, K.J., Response to Thompson and Sterling, 113 245 in the rat, 113 106
Grunau, R.E., Holsti, L., Haley, D.W., Oberlander, T., Weinberg, J., Soli- Ma, W., Zhang, Y., Bantel, C., Eisenach, J.C., Medium and large injured
mano, A., Whitfield, M.F., Fitzgerald, C., Yu, W., Neonatal procedural dorsal root ganglion cells increase TRPV-1, accompanied by increased
pain exposure predicts lower cortisol and behavioral reactivity in a2C-adrenoceptor co-expression and functional inhibition by clonidine,
preterm infants in the NICU, 113 293 113 386
Gustorff, B., see Sycha, T., 113 316 Maarrawi, J., see Montes, C., 113 223
Madeleine, P., see Ge, H.-Y., 113 134
Hafner, H., see Eisenberg, E., 113 99 Magnin, M., see Montes, C., 113 223
Hagen, K., Bj@ro, T., Zwart, J.-A., Svebak, S., Bovim, G., Stovner, L.J., Do Manning, D.C., see Dworkin, R.H., 113 9
high TSH values protect against chronic musculoskeletal complaints? March, L.M., see Blyth, F.M., 113 285
The Nord-Trondelag Health Study (HUNT), 113 416 Marinova, Z., see Tan-No, K., 113 301
Haley, D.W., see Grunau, R.E., 113 293 Martin, S., see Dworkin, R.H., 113 9
Halldner, L., see Wu, W.-P., 113 395 Martin, T.J., Zhang, Y., Buechler, N., Conklin, D.R., Eisenach, J.C.,
Han, J.S., Neugebauer, V., mGluR1 and mGluRS5 antagonists in the amyg- Intrathecal morphine and ketorolac analgesia after surgery: comparison
dala inhibit different components of audible and ultrasonic vocaliza- of spontaneous and elicited responses in rats, 113 376
tions in a model of arthritic pain, 113 211 Mashimo, T., see Mizushima, T., 113 51
Handwerker, H., see Ikoma, A., 113 148 Matthews, E.A., see Stirling, L.C., 113 27
Hanlon, C.A., see Buffington, A.L.H., 113 172 Mauguiere, F., see Montes, C., 113 223
Hansson, P.T., Dickenson, A.H., Pharmacological treatment of peripheral McCormick, C.G., see Dworkin, R.H., 113 9
neuropathic pain conditions based on shared commonalities despite McCracken, L.M., Social context and acceptance of chronic pain: the role
multiple etiologies, 113 251 of solicitous and punishing responses, 113 155
Hao, J.-X., see Wu, W.-P., 113 395 McDermott, M.P., see Dworkin, R.H., 113 9
Harte, S.E., Kender, R.G., Borszcz, G.S., Activation of 5-HT,, and 5-HT; McGrath, P., see Dworkin, R.H., 113 9
receptors in the parafascicular nucleus suppresses the affective reaction McGrath, P.J., see Reid, G.J., 113 201
of rats to noxious stimulation, 113 405 McKeown, M.J., see Buffington, A.L.H., 113 172
Haythornthwaite, J.A., see Dworkin, R.H., 113 9 McQuay, H., Consensus on outcome measures for chronic pain trials, 113 |
Hertz, S., see Dworkin, R.H., 113 9 Merskey, H., Distortion of the biopsychosocial approach, 113 240
Hidding, A., see Gheldof, E.L.M., 113 71 Miaskowski, C., see Paul, S.M., 113 37
Holsti, L., see Grunau, R.E., 113 293 Miglioretti, D.L., see Von Korff, M., 113 323
Miglioretti, D.L., see Von Korff, M., 113 331
Ikoma, A., Handwerker, H., Miyachi, Y., Schmelz, M., Electrically evoked Mikula, K., see Kwan, C.L., 113 160
itch in humans, 113 148 Miyachi, Y., see Ikoma, A., 113 148
Mizushima, T., Obata, K., Yamanaka, H., Dai, Y., Fukuoka, T., Tokunaga,
Jadad, A.R., see Dworkin, R.H., 113 9 A., Mashimo, T., Noguchi, K., Activation of p38 MAPK in primary
Jensen, M.P., see Dworkin, R.H., 113 9 afferent neurons by noxious stimulation and its involvement in the
Jensen, T.S., see Bach, F.W., 113 245 development of thermal hyperalgesia, 113 51
Molliver, D.C., Lindsay, J., Albers, K.M., Davis, B.M., Overexpression of
Kaplan, B., see Eisenberg, E., 113 99 NGF or GDNF alters transcriptional plasticity evoked by inflammation,
Karoly, P., see Ruehlman, L.S., 113 82 113 277
Author Index to Volume 113 (2005) 431-434 433
Montes, C., Magnin, M., Maarrawi, J., Frot, M., Convers, P., Mauguiere, F., Rowbotham, M.C., Goli, V., Kunz, N.R., Lei, D., Corrigendum to **Venla-
Garcia-Larrea, L., Thalamic thermo-algesic transmission: ventral faxine extended release in the treatment of painful diabetic neuropathy:
posterior (VP) complex versus VMpo in the light of a thalamic infarct a double-blind, placebo-controlled study’’ [Pain 110 (2004) 697-706},
with central pain, 113 223 113 248
Moore, J.E., see Von Korff, M., 113 323 Royal, M.A., see Dworkin, R.H., 113 9
Morgan, M.M., Clayton, C.C., Boyer-Quick, J.S., Differential susceptibility Ruehlman, L.S., Karoly, P., Newton, C., Aiken, L.S., The development and
of the PAG and RVM to tolerance to the antinociceptive effect of preliminary validation of a brief measure of chronic pain impact for use
morphine in the rat, 113 91 in the general population, 113 82
Nakagawasai, O., see Tan-No, K., 113 301 Sakurada, S., see Tan-No, K., 113 301
Nassar, M.A., see Stirling, L.C., 113 27 Sato, T., see Tan-No, K., 113 301
Neugebauer, V., see Han, J.S., 113 211 Satoh, S., see Tan-No, K., 113 301
Newton, C., see RuehIman, L.S., 113 82 Saunders, K., see Von Korff, M., 113 323
Nicholas, M.K., see Blyth, F.M., 113 285 Saunders, K., see Von Korff, M., 113 331
Nicol, G.D., see Fehrenbacher, J.C., 113 113 Schmelz, M., see Ikoma, A., 113 148
Niijima, F., see Tan-No, K., 113 301 Schmetterer, L., see Sycha, T., 113 316
Noguchi, K., see Mizushima, T., 113 51 Schreiber, S., see Peles, E., 113 340
Scorr, L., see Sternberg, W.F., 113 347
Oaklander, A.L., see Dey, D.D., 113 233 Sedan, O., Sprecher, E., Yarnitsky, D., Vagal stomach afferents inhibit
Obata, H., Conklin, D., Eisenach, J.C., Spinal noradrenaline transporter somatic pain perception, 113 354
inhibition by reboxetine and Xen2174 reduces tactile hypersensitivity Simon, G., see Von Korff, M., 113 331
after surgery in rats, 113 271 Simon, L., see Dworkin, R.H., 113 9
Obata, K., see Mizushima, T., 113 51 Sindrup, S.H., see Bach, F.W., 113 245
Oberlander, T., see Grunau, R.E., 113 293 Smith, B.H., Elliott, A.M., Active self-management of chronic pain in the
O'Neill, J.P., see Gilron, I., 113 191 community, 113 249
Orr, E., see Gilron, I., 113 19] Smith, L.D., see Sternberg, W.F., 113 347
Smith, M., see Paul, S.M., 113 37
Parada, C.A., Reichling, D.B., Levine, J.D., Chronic hyperalgesic priming Solimano, A., see Grunau, R.E., 113 293
in the rat involves a novel interaction between cAMP and PKCe second Sprecher, E., see Sedan, O., 113 354
messenger pathways, 113 185 Sprenger, T., Valet, M., Platzer, S., Pfaffenrath, V., Steude, U., Tolle, T.R..,
Paul, S.M., Zelman, D.C., Smith, M., Miaskowski, C., Categorizing the SUNCT: bilateral hypothalamic activation during headache attacks and
severity of cancer pain: further exploration of the establishment of resolving of symptoms after trigeminal decompression, 113 422
cutpoints, 113 37 Stang, P., see Von Korff, M., 113 331
Peles, E., Schreiber, S., Gordon, J., Adelson, M., Significantly higher Stauffer, J.W., see Dworkin, R.H., 113 9
methadone dose for methadone maintenance treatment (MMT) patients Stein, W., see Dworkin, R.H., 113 9
with chronic pain, 113 340 Sternberg, W.F., Scorr, L., Smith, L.D., Ridgway, C.G., Stout, M., Long-
Persson, J., see Strigo, L.A., 113 255 term effects of neonatal surgery on adulthood pain behavior, 113 347
Peters, M.L., Vlaeyen, J.W.S., Weber, W.E.J., The joint contribution of Steude, U., see Sprenger, T., 113 422
physical pathology, pain-related fear and catastrophizing to chronic Stirling, L.C., Forlani, G., Baker, M.D., Wood, J.N., Matthews, E.A., Dick-
back pain disability, 113 45 enson, A.H., Nassar, M.A., Nociceptor-specific gene deletion using
Petersen, K.B., see Duedahl, T.H., 113 360 heterozygous Nay1.8-Cre recombinase mice, 113 27
Pfaffenrath, V., see Sprenger, T., 113 422 Stout, M., see Sternberg, W.F., 113 347
Platzer, S., see Sprenger, T., 113 422 Stovner, L.J., see Hagen, K., 113 416
Premkumar, L.S., see Raisinghani, M., 113 123 Strigo, I.A., Duncan, G.H., Bushnell, M.C., Boivin, M., Wainer, I., Rosas,
Puehler, W., Brack, A., Kopf, A., Extensive abscess formation after M.E.R., Persson, J., The effects of racemic ketamine on painful stimu-
repeated paravertebral injections for the treatment of chronic back lation of skin and viscera in human subjects, 113 255
pain, 113 427 Stucki, G., see Dworkin, R.H., 113 9
Sullivan, M.J.L., Lynch, M.E., Clark, A.J., Dimensions of catastrophic
Quessy, S., see Dworkin, R.H., 113 9 thinking associated with pain experience and disability in patients
with neuropathic pain conditions, 113 310
Raisinghani, M., Premkumar, L.S., Block of native and cloned vanilloid Svebak, S., see Hagen, K., 113 416
receptor | (TRPV1) by aminoglycoside antibiotics, 113 123 Sycha, T., Anzenhofer, S., Lehr, S., Schmetterer, L., Chizh, B., Eichler,
Rappaport, B.A., see Dworkin, R.H., 113 9 H.-G., Gustorff, B., Rofecoxib attenuates both primary and secondary
Rasmussen, P.V., see Bach, F.W., 113 245 inflammatory hyperalgesia: a randomized, double blinded, placebo
Reichling, D.B., see Parada, C.A., 113 185 controlled crossover trial in the UV-B pain model, 113 316
Reid, G.J.. McGrath, P.J., Lang, B.A., Parent-child interactions among
children with juvenile fibromyalgia, arthritis, and healthy controls, Tadano, T., see Tan-No, K., 113 301
113 201 Tait, R.C., see Chibnall, J.T., 113 369
Reuben, S.S., The prevention of post-surgical neuralgia, 113 242 Takahashi, H., see Tan-No, K., 113 301
Ridgway, C.G., see Sternberg, W.F., 113 347 Tan-No, K., Takahashi, H., Nakagawasai, O., Niijima, F., Sato, T., Satoh,
Robbins, W., see Dworkin, R.H., 113 9 S., Sakurada, S., Marinova, Z., Yakovleva, T., Bakalkin, G., Terenius,
Robinson, J.P., see Dworkin, R.H., 113 9 L., Tadano, T., Pronociceptive role of dynorphins in uninjured animals:
Rodriguez Rosas, M.E., see Strigo, 1.A., 113 255 N-ethylmaleimide-induced nociceptive behavior mediated through
Rollman, G.B., The need for ecological validity in studies of pain and inhibition of dynorphin degradation, 113 30]
ethnicity, 113 3 Terenius, L., see Tan-No, K., 113 301
Romsing, J., see Duedahl, T.H., 113 360 Theodorou, V., see Ait-Belgnaoui, A., 113 141
Rothman, M., see Dworkin, R.H., 113 9 Thompson, E.N., Letter to the Editor of PAIN, 113 244
434 Author Index to Volume 113 (2005) 431-434
Tokunaga, A., see Mizushima, T., 113 51 Wainer, I., see Strigo, 1.A., 113 255
Tolle, T.R., see Sprenger, T., 113 422 Weber, W.E.J., see Peters, M.L., 113 45
Tollett, J., see Dworkin, R.H., 113 9 Weinberg, J., see Grunau, R.E., 113 293
Tramer, M.R., see Elia, N., 113 61 Wernicke, J., see Dworkin, R.H., 113 9
Tu, D., see Gilron, I., 113 191 Whitfield, M.F., see Grunau, R.E., 113 293
Turk, D.C., see Dworkin, R.H., 113 9 Wiesenfeld-Hallin, Z., see Wu, W.-P., 113 395
Turner, J.A., see Von Korff, M., 113 323 Witter, J., see Dworkin, R.H., 113 9
Wood, J.N., see Stirling, L.C., 113 27
Wu, W.-P., Hao, J.-X., Halldner, L., Lovdahl, C., DeLander, G.E., Wiesen-
Valet, M., see Sprenger, T., 113 422 feld-Hallin, Z., Fredholm, B.B., Xu, X.-J., Increased nociceptive
Van Houdenhove, B., Luyten, P., Beyond dualism: the role of life stress in response in mice lacking the adenosine A, receptor, 113 395
chronic pain, 113 238
Vasko, M.R., see Fehrenbacher, J.C., 113 113 Xu, X.-J., see Wu, W.-P., 113 395
Vinck, J., see Gheldof, E.L.M., 113 71
Vlaeyen, J.W.S., see Gheldof, E.L.M., 113 71 Yakovleva, T., see Tan-No, K., 113 301
Vlaeyen, J.W.S., see Peters, M.L., 113 45 Yamanaka, H., see Mizushima, T., 113 51
Von Korff, M., Balderson, B.H.K., Saunders, K., Miglioretti, D.L., Lin, Yarnitsky, D., see Sedan, O., 113 354
E.H.B., Berry, S., Moore, J.E., Turner, J.A., A trial of an activating Yu, W., see Grunau, R.E., 113 293
intervention for chronic back pain in primary care and physical therapy Yudashkin, M., see Eisenberg, E., 113 99
settings, 113 323
Zamora, J.E., see Gilron, I., 113 191
Von Korff, M., Crane, P., Lane, M., Miglioretti, D.L., Simon, G., Saunders,
Zelman, D.C., see Paul, S.M., 113 37
K., Stang, P., Brandenburg, N., Kessler, R., Chronic spinal pain and
Zhang, Y., see Ma, W., 113 386
physical—mental comorbidity in the United States: results from the
Zhang, Y., see Martin, T.J., 113 376
national comorbidity survey replication, 113 331
Zwart, J.-A., see Hagen, K., 113 416
PAIN
<
=z
Pain 113 (2005) 435-441
www.elsevier.com/locate/pain
Subject Index to Volume 113 (2005)
Abdominal constriction Arthritic pain
Long-term effects of neonatal surgery on adulthood pain behavior, 113, mGluR! and mGluRS5 antagonists in the amygdala inhibit different
347 components of audible and ultrasonic vocalizations in a model of
Abscess arthritic pain, 113, 211
Extensive abscess formation after repeated paravertebral injections for Assessment
the treatment of chronic back pain, 113, 427
Core outcome measures for chronic pain clinical trials; IMMPACT
Acceptance
recommendations, 113, 9
Social context and acceptance of chronic pain: the role of solicitous and
Audible vocalizations
punishing responses, 113, 155
mGluR! and mGluRS5 antagonists in the amygdala inhibit different
Addiction
components of audible and ultrasonic vocalizations in a model of
Significantly higher methadone dose for methadone maintenance treat-
arthritic pain, 113, 211
ment (MMT) patients with chronic pain, 113, 340
Autonomic
Adenylyl cyclase
Neonatal procedural pain exposure predicts lower cortisol and beha-
Chronic hyperalgesic priming in the rat involves a novel interaction
vioral reactivity in preterm infants in the NICU, 113, 293
between cAMP and PKCe second messenger pathways, 113, 185
Adrenergic Autotomy
Medium and large injured dorsal root ganglion cells increase TRPV-1, Central neuropathic itch from spinal-cord cavernous hemangioma: a
accompanied by increased a2C-adrenoceptor co-expression and func- human case, a possible animal model, and hypotheses about pathogen-
tional inhibition by clonidine, 113, 386 esis, 113, 233
Adverse events Axon reflex erythema
Core outcome measures for chronic pain clinical trials: IMMPACT Electrically evoked itch in humans, 113, 148
recommendations, 113, 9 Back pain
Affect A trial of an activating intervention for chronic back pain in primary
mGluR! and mGluRS antagonists in the amygdala inhibit different care and physical therapy settings, 113, 323
components of audible and ultrasonic vocalizations in a model of
Back pain
arthritic pain, 113, 211
Chronic spinal pain and physical—mental comorbidity in the United
Affective pain
States: results from the national comorbidity survey replication, 113,
Dimensions of catastrophic thinking associated with pain experience
331
and disability in patients with neuropathic pain conditions, 113, 310
Back pain
Alloknesis
Extensive abscess formation after repeated paravertebral injections for
Electrically evoked itch in humans, 113, 148
the treatment of chronic back pain, 113, 427
Aminoglycoside antibiotics
Behavior
Block of native and cloned vanilloid receptor | (TRPV1) by aminogly-
Intrathecal morphine and ketorolac analgesia after surgery: comparison
coside antibiotics, 113, 123
of spontaneous and elicited responses in rats, 113, 376
Amygdala
Behavioral models
mGluR! and mGluRS5 antagonists in the amygdala inhibit different
Social context and acceptance of chronic pain: the role of solicitous and
components of audible and ultrasonic vocalizations in a model of
punishing responses, 113, 155
arthritic pain, 113, 211
Analgesia Behaviour
Chronic hyperalgesic priming in the rat involves a novel interaction Nociceptor-specific gene deletion using heterozygous Nay1.8-Cre
between cAMP and PKCe second messenger pathways, 113, 185 recombinase mice, 113, 27
Analgesia Benzodiazepine
Ketamine and postoperative pain — a quantitative systematic review of Significantly higher methadone dose for methadone maintenance treat-
randomised trials, 113, 61 ment (MMT) patients with chronic pain, 113, 340
Analgesia Biopsychosocial model of chronic pain
The effects of racemic ketamine on painful stimulation of skin and The joint contribution of physical pathology, pain-related fear and cata-
viscera in human subjects, 113, 255 strophizing to chronic back pain disability, 113, 45
Animal model
Bone metastasis
Central neuropathic itch from spinal-cord cavernous hemangioma: a
Categorizing the severity of cancer pain: further exploration of the
human case, a possible animal model, and hypotheses about pathogen-
establishment of cutpoints, 113, 37
esis, 113, 233
Brief screening
Anti-hyperalgesia
The development and preliminary validation of a brief measure of
Intravenous dextromethorphan to human volunteers: relationship
chronic pain impact for use in the general population, 113, 82
between pharmacokinetics and anti-hyperalgesic effect, 113, 360
doi: 10.1016/S0304-3959(04)0061 1-6
436 Subject Index to Volume 113 (2005) 435-441
Cancer pain Cognitive-behavioral
Categorizing the severity of cancer pain: further exploration of the A trial of an activating intervention for chronic back pain in primary
establishment of cutpoints, 113, 37 care and physical therapy settings, 113, 323
Capsaicin Colonic paracellular permeability
Activation of p38 MAPK in primary afferent neurons by noxious stimu- Acute stress-induced hypersensitivity to colonic distension depends
lation and its involvement in the development of thermal hyperalgesia, upon increase in paracellular permeability: role of myosin light chain
113, 51 kinase, 113, 141
Capsaicin Complex regional pain syndrome
Block of native and cloned vanilloid receptor | (TRPV1) by aminogly- Evidence for cortical hyperexcitability of the affected limb representa-
coside antibiotics, 113, 123 tion area in CRPS: a psychophysical and transcranial magnetic stimula-
Capsaicin tion study, 113, 99
Medium and large injured dorsal root ganglion cells increase TRPV-1, Cortical excitability
accompanied by increased a2C-adrenoceptor co-expression and func- Evidence for cortical hyperexcitability of the affected limb representa-
tional inhibition by clonidine, 113, 386 tion area in CRPS: a psychophysical and transcranial magnetic stimula-
Catastrophizing tion study, 113, 99
Confirmatory factor analysis of the Pain Catastrophizing Scale in Afri- Cortisol
can American and Caucasian Workers’ Compensation claimants with Neonatal procedural pain exposure predicts lower cortisol and beha-
low back injuries, 113, 369 vioral reactivity in preterm infants in the NICU, 113, 293
Catastrophizing
CPCCOEt
Dimensions of catastrophic thinking associated with pain experience
mGluR1I and mGluRS5 antagonists in the amygdala inhibit different
and disability in patients with neuropathic pain conditions, 113, 310
components of audible and ultrasonic vocalizations in a model of
Catastrophizing arthritic pain, 113, 211
The joint contribution of physical pathology, pain-related fear and cata-
Cre-loxP
strophizing to chronic back pain disability, 113, 45
Nociceptor-specific gene deletion using heterozygous Nay1.8-Cre
Cell culture
recombinase mice, 113, 27
Enhanced excitability of dissociated primary sensory neurons after
Cross-sectional
chronic compression of the dorsal root ganglion in the rat, 113, 106
The differential role of pain, work characteristics and pain-related fear
Central lateral nucleus
in explaining back pain and sick leave in occupational settings, 113, 71
Activation of 5-HT,, and 5-HT; receptors in the parafascicular nucleus
Cutpoints for pain severity
suppresses the affective reaction of rats to noxious stimulation, 113, 405
Categorizing the severity of cancer pain: further exploration of the
Central pain
establishment of cutpoints, 113, 37
Thalamic thermo-algesic transmission: ventral posterior (VP) complex
Cyclooxygenase
versus VMpo in the light of a thalamic infarct with central pain, 113,
Intrathecal morphine and ketorolac analgesia after surgery: comparison
993
of spontaneous and elicited responses in rats, 113, 376
Central sensitization
Cyclooxygenase
Electrically evoked itch in humans, 113, 148
Tumor necrosis factor a and interleukin-18 stimulate the expression of
Chronic disease
cyclooxygenase II but do not alter prostaglandin E, receptor mRNA
Chronic spinal pain and physical—mental comorbidity in the United
levels in cultured dorsal root ganglia cells, 113, 113
States: results from the national comorbidity survey replication, 113,
Cytokine
33]
Tumor necrosis factor a and interleukin-18 stimulate the expression of
Chronic pain
cyclooxygenase II but do not alter prostaglandin E, receptor mRNA
A trial of an activating intervention for chronic back pain in primary
levels in cultured dorsal root ganglia cells, 113, 113
care and physical therapy settings, 113, 323
Dextromethorphan
Chronic pain
Intravenous dextromethorphan to human volunteers: relationship
Chronic hyperalgesic priming in the rat involves a novel interaction
between pharmacokinetics and anti-hyperalgesic effect, 113, 360
between cAMP and PKCe second messenger pathways, 113, 185
Disability
Chronic pain
A trial of an activating intervention for chronic back pain in primary
Chronic spinal pain and physical—mental comorbidity in the United
care and physical therapy settings, 113, 323
States: results from the national comorbidity survey replication, 113,
331 Disability
Chronic pain Chronic spinal pain and physical—mental comorbidity in the United
Core outcome measures for chronic pain clinical trials: IMMPACT States: results from the national comorbidity survey replication, 113,
recommendations, 113, 9 331
Chronic pain Disability
Self-management of chronic pain: a population-based study, 113, 285 The joint contribution of physical pathology, pain-related fear and cata-
Chronic pain strophizing to chronic back pain disability, 113, 45
Significantly higher methadone dose for methadone maintenance treat- Dorsal root ganglia
ment (MMT) patients with chronic pain, 113, 340 Tumor necrosis factor a and interleukin-1f stimulate the expression of
Chronic pain cyclooxygenase II but do not alter prostaglandin E, receptor mRNA
Social context and acceptance of chronic pain: the role of solicitous and levels in cultured dorsal root ganglia cells, 113, 113
punishing responses, 113, 155 Dorsal root ganglion
Chronic pain Activation of p38 MAPK in primary afferent neurons by noxious stimu-
The development and preliminary validation of a brief measure of lation and its involvement in the development of thermal hyperalgesia,
chronic pain impact for use in the general population, 113, 82 113, 5]
Clinical trials Dorsal root ganglion
Core outcome measures for chronic pain clinical trials: IMMPACT Enhanced excitability of dissociated primary sensory neurons after
recommendations, 113, 9 chronic compression of the dorsal root ganglion in the rat, 113, 106
Subject Index to Volume 113 (2005) 435-441 437
Dorsal root ganglion Helplessness
Medium and large injured dorsal root ganglion cells increase TRPV-1, Dimensions of catastrophic thinking associated with pain experience
accompanied by increased a2C-adrenoceptor co-expression and func- and disability in patients with neuropathic pain conditions, 113, 310
tional inhibition by clonidine, 113, 386 Hot-plate
Dynorphins Long-term effects of neonatal surgery on adulthood pain behavior, 113,
Pronociceptive role of dynorphins in uninjured animals: N-ethylmalei- 347
mide-induced nociceptive behavior mediated through inhibition of Hyperalgesia
dynorphin degradation, 113, 301 Increased nociceptive response in mice lacking the adenosine A, recep-
Emotional burden tor, 113, 395
The development and preliminary validation of a brief measure of Hyperexcitability
chronic pain impact for use in the general population, 113, 82 Enhanced excitability of dissociated primary sensory neurons after
Emotional functioning chronic compression of the dorsal root ganglion in the rat, 113, 106
Core outcome measures for chronic pain clinical trials: IMMPACT Hypothalamus
recommendations, 113, 9 SUNCT: bilateral hypothalamic activation during headache attacks and
Epidemiology resolving of symptoms after trigeminal decompression, 113, 422
Do high TSH values protect against chronic musculoskeletal Hysterectomy
complaints? The Nord-Tr@ndelag Health Study (HUNT), 113, 416 A placebo-controlled randomized clinical trial of perioperative
Epidemiology administration of gabapentin, rofecoxib and their combination for spon-
Self-management of chronic pain: a population-based study, 113, 285 taneous and movement-evoked pain after abdominal hysterectomy,
ERK 113, 191
Activation of p38 MAPK in primary afferent neurons by noxious stimu- Immunocytochemistry
lation and its involvement in the development of thermal hyperalgesia, Medium and large injured dorsal root ganglion cells increase TRPV-1,
113, 51 accompanied by increased a2C-adrenoceptor co-expression and func-
Evoked potential tional inhibition by clonidine, 113, 386
Thalamic thermo-algesic transmission: ventral posterior (VP) complex Inflammation
versus VMpo in the light of a thalamic infarct with central pain, 113, Chronic hyperalgesic priming in the rat involves a novel interaction
223 between cAMP and PKCée second messenger pathways, 113, 185
Excessive grooming Inflammation
Central neuropathic itch from spinal-cord cavernous hemangioma: a Increased nociceptive response in mice lacking the adenosine A, recep-
human case, a possible animal model, and hypotheses about pathogen- tor, 113, 395
esis, 113, 233 Inflammation
Experimental pain Overexpression of NGF or GDNF alters transcriptional plasticity
Ethnic differences in responses to multiple experimental pain stimuli, evoked by inflammation, 113, 277
113, 20 Intracellular calcium
Experimental pain Medium and large injured dorsal root ganglion cells increase TRPV-1,
Gender differences in pain modulation evoked by repeated injections of accompanied by increased a2C-adrenoceptor co-expression and func-
glutamate into the human trapezius muscle, 113, 134 tional inhibition by clonidine, 113, 386
Experimental pain model Intralaminar thalamus
Intravenous dextromethorphan to human volunteers: relationship Activation of 5-HT,, and 5-HT> receptors in the parafascicular nucleus
between pharmacokinetics and anti-hyperalgesic effect, 113, 360 suppresses the affective reaction of rats to noxious stimulation, 113, 405
Facial reactivity Intrathecal
Neonatal procedural pain exposure predicts lower cortisol and beha- Spinal noradrenaline transporter inhibition by reboxetine and Xen2174
vioral reactivity in preterm infants in the NICU, 113, 293 reduces tactile hypersensitivity after surgery in rats, 113, 271
Fibromyalgia Intrathecal administration
Parent—child interactions among children with juvenile fibromyalgia, Pronociceptive role of dynorphins in uninjured animals: N-ethylmalei-
arthritis, and healthy controls, 113, 201 mide-induced nociceptive behavior mediated through inhibition of
fMRI dynorphin degradation, 113, 301
SUNCT: bilateral hypothalamic activation during headache attacks and Irritable bowel syndrome
resolving of symptoms after trigeminal decompression, 113, 422 Characteristics of rectal perception are altered in irritable bowel
Gabapentin syndrome, 113, 160
A placebo-controlled randomized clinical trial of perioperative Jannetta procedure
administration of gabapentin, rofecoxib and their combination for spon- SUNCT: bilateral hypothalamic activation during headache attacks and
taneous and movement-evoked pain after abdominal hysterectomy, resolving of symptoms after trigeminal decompression, 113, 422
113, 191 Job stress
Global ratings The differential role of pain, work characteristics and pain-related fear
Core outcome measures for chronic pain clinical trials; IMMPACT in explaining back pain and sick leave in occupational settings, 113, 71
recommendations, 113, 9 Juvenile rheumatoid arthritis
Growth factors Parent-child interactions among children with juvenile fibromyalgia,
Overexpression of NGF or GDNF alters transcriptional plasticity arthritis, and healthy controls, 113, 201
evoked by inflammation, 113, 277 Knock-out
Health-related quality of life Nociceptor-specific gene deletion using heterozygous Nay!.8-Cre
Core outcome measures for chronic pain clinical trials: IMMPACT recombinase mice, 113, 27
recommendations, 113, 9 Laser-evoked potential
Heat Thalamic thermo-algesic transmission: ventral posterior (VP) complex
The effects of racemic ketamine on painful stimulation of skin and versus VMpo in the light of a thalamic infarct with central pain, 113,
viscera in human subjects, 113, 255 223
438 Subject Index to Volume 113 (2005) 435-441
Low back pain Neonatal surgery
Confirmatory factor analysis of the Pain Catastrophizing Scale in Afri- Long-term effects of neonatal surgery on adulthood pain behavior, 113,
can American and Caucasian Workers’ compensaiion claimants with 347
low back injuries, 113, 369 N-ethylmaleimide
Low back pain Pronociceptive role of dynorphins in uninjured animals: N-ethylmalei-
The differential role of pain, work characteristics and pain-related fear mide-induced nociceptive behavior mediated through inhibition of
in explaining back pain and sick leave in occupational settings, 113, 71 dynorphin degradation, 113, 301
Measurement Neuropathic pain
Confirmatory factor analysis of the Pain Catastrophizing Scale in Afri- Dimensions of catastrophic thinking associated with pain experience
can American and Caucasian Workers’ compensation claimants with and disability in patients with neuropathic pain conditions, 113, 310
iow back injuries, 113, 369 Neuropathic pain
Medial thalamus Enhanced excitability of dissociated primary sensory neurons after
Activation of 5-HT,, and 5-HT> receptors in the parafascicular nucleus chronic compression of the dorsal root ganglion in the rat, 113, 106
suppresses the affective reaction of rats to noxious stimulation, 113, 405
Neuropathic pain
Mental disorders Increased nociceptive response in mice lacking the adenosine A, recep-
Chronic spinal pain and physical—mental comorbidity in the United tor, 113, 395
States: results from the national comorbidity survey replication, 113, NMDA-R
331 The effects of racemic ketamine on painful stimulation of skin and
Meta-analysis viscera in human subjects, 113, 255
Ketamine and postoperative pain — a quantitative systematic review of
N-methyl-D-aspartate receptor ion-channel complex
randomised trials, 113, 61
Pronociceptive role of dynorphins in uninjured animals: N-ethylmalei-
Metabotropic glutamate receptors mide-induced nociceptive behavior mediated through inhibition of
mGluR1I and mGluRS5 antagonists in the amygdala inhibit different dynorphin degradation, 113, 301
components of audible and ultrasonic vocalizations in a model of
Nociception
arthritic pain, 113, 211
Electrically evoked itch in humans, 113, 148
Methadone dosage
Nociception
Significantly higher methadone dose for methadone maintenance treat-
Increased nociceptive response in mice lacking the adenosine A, recep-
ment (MMT) patients with chronic pain, 113, 340
tor, 113, 395
Methadone maintenance treatment (MMT)
Nociception
Significantly higher methadone dose for methadone maintenance treat-
mGluR! and mGluRS5 antagonists in the amygdala inhibit different
ment (MMT) patients with chronic pain, 113, 340
components of audible and ultrasonic vocalizations in a model of
Mice
arthritic pain, 113, 211
Increased nociceptive response in mice lacking the adenosine A, recep-
Nociception
tor, 113, 395
Overexpression of NGF or GDNF alters transcriptional plasticity
MLCK
evoked by inflammation, 113, 277
Acute stress-induced hypersensitivity to colonic distension depends
Nociception
upon increase in paracellular permeability: role of myosin light chain
Thalamic thermo-algesic transmission: ventral posterior (VP) complex
kinase, 113, 141
versus VMpo in the light of a thalamic infarct with central pain, 113,
Morphine
223
Increased nociceptive response in mice lacking the adenosine A, recep-
Nociception
tor, 113, 395
The effect on mechanical pain threshold over human muscles by oral
Morphine
administration of granisetron and diclofenac-sodium, 113, 265
Neonatal procedural pain exposure predicts lower cortisol and beha-
Nociception
vioral reactivity in preterm infants in the NICU, 113, 293
The effects of racemic ketamine on painful stimulation of skin and
Movement-evoked pain
viscera in human subjects, 113, 255
A placebo-controlled randomized clinical trial of perioperative
Nociceptive behavior
administration of gabapentin, rofecoxib and their combination for spon-
Pronociceptive role of dynorphins in uninjured animals: N-ethylmalei-
taneous and movement-evoked pain after abdominal hysterectomy,
mide-induced nociceptive behavior mediated through inhibition of
113, 191
dynorphin degradation, 113, 301
MPEP
Noradrenaline transporter
mGluR! and mGluRS5 antagonists in the amygdala inhibit different
Spinal noradrenaline transporter inhibition by reboxetine and Xen2174
components of audible and ultrasonic vocalizations in a model of
reduces tactile hypersensitivity after surgery in rats, 113, 271
arthritic pain, 113, 211
8-OH-DPAT
Multidisciplinary treatment
Activation of 5-HT,, and 5-HT> receptors in the parafascicular nucleus
Social context and acceptance of chronic pain: the role of solicitous and
suppresses the affective reaction of rats to noxious stimulation, 113, 405
punishing responses, 113, 155
Opiate
Musculoskeletal
Differential susceptibility of the PAG and RVM to tolerance to the
Do high TSH values protect against chronic musculoskeletal
antinociceptive effect of morphine in the rat, 113, 91
complaints? The Nord-Tréndelag Health Study (HUNT), 113, 416
Opioid receptor
Neck pain
Intrathecal morphine and ketorolac analgesia after surgery: comparison
Chronic spinal pain and physical—mental comorbidity in the United
of spontaneous and elicited responses in rats, 113, 376
States: results from the national comorbidity survey replication, 113,
33] Outcomes
Core outcome measures for chronic pain clinical trials:s IMMPACT
Neomycin
recommendations, 113, 9
Block of native and cloned vanilloid receptor | (TRPV1) by aminogly-
coside antibiotics, 113, 123
Subject Index to Volume 113 (2005) 435-44]
p38 Pharmacokinetics—pharmacodynamics
Activation of p38 MAPK in primary afferent neurons by noxious stimu- Intravenous dextromethorphan to human volunteers: relationship
lation and its involvement in the development of thermal hyperalgesia, between pharmacokinetics and anti-hyperalgesic effect, 113, 360
113, 5! Physical functioning
Pain Core outcome measures for chronic pain clinical trials: IMMPACT
Activation of 5-HT,, and 5-HT; receptors in the parafascicular nucleus recommendations, 113, 9
suppresses the affective reaction of rats to noxious stimulation, 113, 405 Physical pathology
Pain The joint contribution of physical pathology, pain-related fear and cata-
strophizing to chronic back pain disability, 113, 45
Central neuropathic itch from spinal-cord cavernous hemangioma: a
human case, a possible animal model, and hypotheses about pathogen- Physical therapy
esis, 113, 233 A trial of an activating intervention for chronic back pain in primary
Pain care and physical therapy settings, 113, 323
Plasticity
Characteristics of rectal perception are altered in irritable bowel
syndrome, 113, 160 Overexpression of NGF or GDNF alters transcriptional plasticity
evoked by inflammation, 113, 277
Pain
Posterior part of the ventral medial nucleus (VMpo)
Ketamine and postoperative pain — a quantitative systematic review of
Thalamic thermo-algesic transmission: ventral posterior (VP) complex
randomised trials, 113, 61
versus VMpo in the light of a thalamic infarct with central pain, 113,
Pain
223
Neonatal procedural pain exposure predicts lower cortisol and beha-
Postoperative
vioral reactivity in preterm infants in the NICU, 113, 293
Ketamine and postoperative pain — a quantitative systematic review of
Pain
randomised trials, 113, 61
Nociceptor-specific gene deletion using heterozygous Nay1.8-Cre
Postoperative pain
recombinase mice, 113, 27
A placebo-controlled randomized clinical trial of perioperative
Pain
administration of gabapentin, rofecoxib and their combination for spon-
Overexpression of NGF or GDNF alters transcriptional plasticity
taneous and movement-evoked pain after abdominal hysterectomy,
evoked by inflammation, 113, 277
113, 191
Pain
Postoperative pain
Vagal stomach afferents inhibit somatic pain perception, 113, 354
Spinal noradrenaline transporter inhibition by reboxetine and Xen2174
Pain Catastrophizing Scale reduces tactile hypersensitivity after surgery in rats, 113, 27]
Confirmatory factor analysis of the Pain Catastrophizing Scale in Afri- Postoperative pain
can American and Caucasian Workers’ compensation claimants with Intrathecal morphine and ketorolac analgesia after surgery: comparison
low back injuries, 113, 369 of spontaneous and elicited responses in rats, 113, 376
Pain habituation Pressure
Gender differences in pain modulation evoked by repeated injections of The effects of racemic ketamine on painful stimulation of skin and
glutamate into the human trapezius muscle, 113, 134 viscera in human subjects, 113, 255
Pain intensity Pressure pain threshold
The joint contribution of physical pathology, pain-related fear and cata- Gender differences in pain modulation evoked by repeated injections of
strophizing to chronic back pain disability, 113, 45 glutamate into the human trapezius muscle, 113, 134
Pain interference Preterm infant
The development and preliminary validation of a brief measure of Neonatal procedural pain exposure predicts lower cortisol and beha-
chronic pain impact for use in the general population, 113, 82 vioral reactivity in preterm infants in the NICU, 113, 293
Pain-related fear Prevalence
The differential role of pain, work characteristics and pain-related fear Chronic spinal pain and physical—mental comorbidity in the United
in explaining back pain and sick leave in occupational settings, 113, 71 States: results from the national comorbidity survey replication, 113,
331
Pain-related fear
Prevalence
The joint contribution of physical pathology, pain-related fear and cata-
Significantly higher methadone dose for methadone maintenance treat-
strophizing to chronic back pain disability, 113, 45
ment (MMT) patients with chronic pain, 113, 340
Pain severity
Primary care
The development and preliminary validation of a brief measure of
A trial of an activating intervention for chronic back pain in primary
chronic pain impact for use in the general population, 113, 82
care and physical therapy settings, 113, 323
Pain threshold
Prodynorphin knockout mice
The effect on mechanical pain threshold over human muscles by oral
Pronociceptive role of dynorphins in uninjured animals: N-ethylmalei-
administration of granisetron and diclofenac-sodium, 113, 265
mide-induced nociceptive behavior mediated through inhibition of
Parasympathetic
dynorphin degradation, 113, 301
Vagal stomach afferents inhibit somatic pain perception, 113, 354
Prostaglandin E,
Paravertebral injection
The effect on mechanical pain threshold over human muscles by oral
Extensive abscess formation after repeated paravertebral injections for
administration of granisetron and diclofenac-sodium, 113, 265
the treatment of chronic back pain, 113, 427
Prostaglandin E,
Parent—child interactions Tumor necrosis factor a and interleukin-18 stimulate the expression of
Parent—child interactions among children with juvenile fibromyalgia, cyclooxygenase II but do not alter prostaglandin E, receptor mRNA
arthritis, and healthy controls, 113, 201 levels in cultured dorsal root ganglia cells, 113, 113
Peripheral nerve Prostaglandin receptor
Medium and large injured dorsal root ganglion cells increase TRPV-1, Tumor necrosis factor a and interleukin-18 stimulate the expression of
accompanied by increased a2C-adrenoceptor co-expression and func- cyclooxygenase II but do not alter prostaglandin E, receptor mRNA
tional inhibition by clonidine, 113, 386 levels in cultured dorsal root ganglia cells, 113, 113
440 Subject Index to Volume 113 (2005) 435-441
Pruritus Skeletal muscle
Central neuropathic itch from spinal-cord cavernous hemangioma: a The effect on mechanical pain threshold over human muscles by oral
human case, a possible animal model, and hypotheses about pathogen- administration of granisetron and diclofenac-sodium, 113, 265
esis, 113, 233 Social influences
Pruritus Social context and acceptance of chronic pain: the role of solicitous and
Electrically evoked itch in humans, 113, 148 punishing responses, 113, 155
Psychophysics Sodium channel
Characteristics of rectal perception are altered in irritable bowel Nociceptor-specific gene deletion using heterozygous Nay1!.8-Cre
syndrome, 113, 160 recombinase mice, 113, 27
Psychophysics Spinal analgesia
The effects of racemic ketamine on painful stimulation of skin and Intrathecal morphine and ketorolac analgesia after surgery: comparison
viscera in human subjects, 113, 255 of spontaneous and elicited responses in rats, 113, 376
Quantitative sensory testing Spinal cord injury
Evidence for cortical hyperexcitability of the affected limb representa- Central neuropathic itch from spinal-cord cavernous hemangioma: a
tion area in CRPS: a psychophysical and transcranial magnetic stimula- human case, a possible animal model, and hypotheses about pathogen-
tion study, 113, 99 esis, 113, 233
Race
Spinal projection
Confirmatory factor analysis of the Pain Catastrophizing Scale in Afri-
Thalamic thermo-algesic transmission: ventral posterior (VP) complex
can American and Caucasian Workers’ compensation claimants with
versus VMpo in the light of a thalamic infarct with central pain, 113,
low back injuries, 113, 369
993
Randomized controlled trials
Spontaneous activity
Core outcome measures for chronic pain clinical trials:) IMMPACT
Enhanced excitability of dissociated primary sensory neurons after
recommendations, 113, 9
chronic compression of the dorsal root ganglion in the rat, 113, 106
Rats
Stress
Spinal noradrenaline transporter inhibition by reboxetine and Xen2174
Acute stress-induced hypersensitivity to colonic distension depends
reduces tactile hypersensitivity after surgery in rats, 113, 271
upon increase in paracellular permeability: role of myosin light chain
Reboxetine
kinase, 113, 141
Spinal noradrenaline transporter inhibition by reboxetine and Xen2174
Stress
reduces tactile hypersensitivity after surgery in rats, 113, 27]
Neonatal procedural pain exposure predicts lower cortisol and beha-
Rectum
vioral reactivity in preterm infants in the NICU, 113, 293
Characteristics of rectal perception are altered in irritable bowel
SUNCT
syndrome, 113, 160
SUNCT: bilateral hypothalamic activation during headache attacks and
Repetitive strain
resolving of symptoms after trigeminal decompression, 113, 422
Chronic hyperalgesic priming in the rat involves a novel interaction
Surgery
between cAMP and PKCe second messenger pathways, 113, 185
Ketamine and postoperative pain — a quantitative systematic review of
Rofecoxib
randomised trials, 113, 61
A placebo-controlled randomized clinical trial of perioperative
Survey
administration of gabapentin, rofecoxib and their combination for spon-
Chronic spinal pain and physical—mental comorbidity in the United
taneous and movement-evoked pain after abdominal hysterectomy,
States: results from the national comorbidity survey replication, 113,
113, 191
331
SB-269970
Systematic review
Activation of 5-HT,, and 5-HT; receptors in the parafascicular nucleus
Ketamine and postoperative pain — a quantitative systematic review of
suppresses the affective reaction of rats to noxious stimulation, 113, 405
randomised trials, 113, 61
Self-care
Tail-withdrawal
Self-management of chronic pain: a population-based study, 113, 285
Long-term effects of neonatal surgery on adulthood pain behavior, 113,
Self-management
347
A trial of an activating intervention for chronic back pain in primary
Temporal summation
care and physical therapy settings, 113, 323
Sensory neuron Gender differences in pain modulation evoked by repeated injections of
glutamate into the human trapezius muscle, 113, 134
Tumor necrosis factor a and interleukin-18 stimulate the expression of
cyclooxygenase II but do not alter prostaglandin E, receptor mRNA Thermal stimuli
levels in cultured dorsal root ganglia cells, 113, 113 Activation of p38 MAPK in primary afferent neurons by noxious stimu-
Sequential analyses lation and its involvement in the development of thermal hyperalgesia,
Parent—child interactions among children with juvenile fibromyalgia, 113, 51
arthritis, and healthy controls, 113, 201 Thyroid dysfunction
Serotonin 5-HT; antagonist Do high TSH values protect against chronic musculoskeletal
The effect on mechanical pain threshold over human muscles by oral complaints? The Nord-Tr@ndelag Health Study (HUNT), 113, 416
administration of granisetron and diclofenac-sodium, 113, 265 Transcranial magnetic stimulation
Sex difference Evidence for cortical hyperexcitability of the affected limb representa-
The effect on mechanical pain threshold over human muscles by oral tion area in CRPS: a psychophysical and transcranial magnetic stimula-
administration of granisetron and diclofenac-sodium, 113, 265 tion study, 113, 99
Sex differences Transcription
Gender differences in pain modulation evoked by repeated injections of Overexpression of NGF or GDNF alters transcriptional plasticity
glutamate into the human trapezius muscle, 113, 134 evoked by inflammation, 113, 277
Sick leave Trigeminal autonomic cephalgia
The differential role of pain, work characteristics and pain-related fear SUNCT: bilateral hypothalamic activation during headache attacks and
in explaining back pain and sick leave in occupational settings, 113, 71 resolving of symptoms after trigeminal decompression, 113, 422